Haeryun Lee Selected Research

2- ((3,5- bis(trifluoromethylphenyl))hydroxymethyl)- 2- (4- nitrophenylamino)- 6- phenyl- 1,2,4a,7a- tetrahydropyrrolo(3,4- b)pyridine- 5,7- dione

9/2008

A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haeryun Lee Research Topics

Disease

1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neurodevelopmental Disorders 01/2016
1	Schizophrenia (Dementia Praecox) 03/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2010
1	Hodgkin Disease (Hodgkin's Disease) 09/2008
1	Neoplasms (Cancer) 09/2008

Drug/Important Bio-Agent (IBA)

1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ElementsIBA 01/2016
1	CalciumIBA 03/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2012
1	Histone Deacetylase InhibitorsIBA 01/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2012
1	NADH DehydrogenaseIBA 10/2010
1	Adenosine Triphosphate (ATP)IBA 10/2010
1	Tyrosine (L-Tyrosine)FDA Link 09/2008
1	2- ((3,5- bis(trifluoromethylphenyl))hydroxymethyl)- 2- (4- nitrophenylamino)- 6- phenyl- 1,2,4a,7a- tetrahydropyrrolo(3,4- b)pyridine- 5,7- dioneIBA 09/2008